This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4g6k
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| + | |||
==Crystal structure of the therapeutic antibody binding fragment of gevokizumab in its unbound state== | ==Crystal structure of the therapeutic antibody binding fragment of gevokizumab in its unbound state== | ||
<StructureSection load='4g6k' size='340' side='right' caption='[[4g6k]], [[Resolution|resolution]] 1.90Å' scene=''> | <StructureSection load='4g6k' size='340' side='right' caption='[[4g6k]], [[Resolution|resolution]] 1.90Å' scene=''> | ||
| Line 4: | Line 5: | ||
<table><tr><td colspan='2'>[[4g6k]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4G6K OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4G6K FirstGlance]. <br> | <table><tr><td colspan='2'>[[4g6k]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4G6K OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4G6K FirstGlance]. <br> | ||
</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4g6j|4g6j]], [[4g6m|4g6m]], [[4g5z|4g5z]]</td></tr> | </td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4g6j|4g6j]], [[4g6m|4g6m]], [[4g5z|4g5z]]</td></tr> | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4g6k FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4g6k OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4g6k RCSB], [http://www.ebi.ac.uk/pdbsum/4g6k PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4g6k FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4g6k OCA], [http://pdbe.org/4g6k PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4g6k RCSB], [http://www.ebi.ac.uk/pdbsum/4g6k PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4g6k ProSAT]</span></td></tr> |
</table> | </table> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
| Line 14: | Line 15: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
| + | <div class="pdbe-citations 4g6k" style="background-color:#fffaf0;"></div> | ||
==See Also== | ==See Also== | ||
| - | *[[ | + | *[[3D structures of monoclonal antibody|3D structures of monoclonal antibody]] |
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 22:10, 4 August 2016
Crystal structure of the therapeutic antibody binding fragment of gevokizumab in its unbound state
| |||||||||||
